San Diego-based mostly Viking Therapeutics marked by itself as a significant competitor in the weight loss drug marketplace in February after revealing promising facts from a mid-stage trial of experimental drug VK2735, which recommended it rivaled—and outperformed—Novo and Lilly drugs when presented being a weekly injection and in March the co… Read More